Tricuspid regurgitation velocity and other biomarkers of mortality in children, adolescents and young adults with sickle cell disease in the United States: The PUSH study

In the US, mortality in sickle cell disease (SCD) increases after age 18–20 years. Biomarkers of mortality risk can identify patients who need intensive follow-up and early or novel interventions. We prospectively enrolled 510 SCD patients aged 3–20 years into an observational study in 2006–2010 and...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Am J Hematol
Glavni autori: Nouraie, Mehdi, Darbari, Deepika S., Rana, Sohail, Minniti, Caterina P., Castro, Oswaldo L., Luchtman-Jones, Lori, Sable, Craig, Dham, Niti, Kato, Gregory J., Gladwin, Mark T., Ensing, Gregory, Arteta, Manuel, Campbell, Andrew, Taylor, James G., Nekhai, Sergei, Gordeuk, Victor R.
Format: Artigo
Jezik:Inglês
Izdano: 2020
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7735042/
https://ncbi.nlm.nih.gov/pubmed/32243618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.25799
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items